We have come so far from PL3, I think it would be naïve to think the company is in the same situation.
- PL4 worked at 60nm
- The etching issue causing the failure of PL3 was fixed by a completely new pattern. You would expect the testing process at imec to change to include new steps in testing of the failure to make sure it has not re-occured, before they conclude the lot is manufactured successfully.
- The company moved from an in house test jig to an actual commercial test system - and when they did so, they were able to get conclusive results from PL3 that they were not able to get on their own system.
- Forums
- ASX - By Stock
- Ann: imec Shipment of Fifth Platform Lot
We have come so far from PL3, I think it would be naïve to think...
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
-0.002(2.38%) |
Mkt cap ! $144.6M |
Open | High | Low | Value | Volume |
8.5¢ | 8.8¢ | 8.2¢ | $105.8K | 1.249M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 130206 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 139429 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 130206 | 0.082 |
8 | 730456 | 0.081 |
7 | 1005933 | 0.080 |
1 | 1211 | 0.079 |
4 | 1256300 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 139429 | 2 |
0.086 | 183888 | 3 |
0.087 | 116362 | 2 |
0.088 | 115000 | 2 |
0.089 | 11000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online